Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2018.474 | Randomized phase II study of combination androgen deprivation therapy (ADT) and radiotherapy in high risk prostate cancer: Stereotactic body Radiotherapy vs conventionAl IMRT to prostate and pelvic nodes (SRAM study) | Dr. POON Darren M.C. |
2019.411 | The Excessive Mortality in Nasopharyngeal Carcinoma (NPC) Survivors ≥ 5 years |
Dr. POON Darren M.C. 潘明駿 |
2019.528 | Stratification of Indolent Versus Aggressive Prostate Cancer plus the Determination of Druggable Gene Targets for Aggressive Prostate Cancer: A Retrospective Study Using Archival Biopsy Samples | Dr. POON Darren M.C. |
2019.649 | PSMA-PET guided Stereotactic Ablative Body Radiotherapy for Oligometastasis in metastatic castration-resistant prostate cancer (mCRPC) with progression on Enzalutamide (PMSABR study) |
Dr. POON Darren MC 潘明駿 |
2018.472 | A Phase 2, Randomized, Open-label Study of Nivolumab or Nivolumab/BMS-986205 Alone or Combined with Intravesical BCG in Participants with BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer (CheckMate 9UT: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 9UT) |
Dr. POON Darren Ming Chun 潘明駿 |
2020.055 | An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants with Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies | Dr. POON Darren Ming Chun |
2018.459 | Retrospective study of docetaxel-related neutropenic sepsis in metastatic hormonal-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC) |
Dr. POON Darren Ming Chun 潘明駿 |
2019.333 | A Randomized, Double-Blind, Controlled Phase 3 Study of Cabozantinib in Combination with Nivolumab and Ipilimumab versus Nivolumab and Ipilimumab in Subjects with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma of Intermediate or Poor Risk |
Dr. POON Darren Ming Chun 潘明駿 |
2019.613 | A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer (CheckMate 7DX: CHECKpoint pathway and nivoluMAB clinical Trial Evaluation 7DX) |
Dr. POON Darren Ming Chun 潘明駿 |
2011.603 | A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER | Dr. POON Darren Ming Chun |
2018.036 | A randomized, open label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877)compared to chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma who have received prior platinumcontaining chemotherapy |
Dr. POON Darren Ming Chun 潘明駿醫生 |
2016.347 | Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-199) |
Dr. POON Darren Ming Chun 潘明駿醫生 |
2016.302 | A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB (ANTI−PD-L1 ANTIBODY) AS MONOTHERAPY AND IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA |
Dr. POON Darren Ming Chun 潘明駿 |
2017.067 | Study on Epidemiology and Clinical Features of Patients Diagnosed with Nasopharyngeal Carcinoma at less than 20 years old in Hong Kong from 1993-2012 |
Dr. POON Darren Ming Chun 潘明駿 |
2019.630 | Survival Estimate Models of Cancer Patients with Spinal Metastases: Big Data Analytics to Aid Daily Clinical Practice |
Dr. POON Darren Ming Chun 潘明駿 |
2022.312 | Cardiovascular investigation of Coronavirus Disease 2019 (COVID-19) |
Prof. POON Ellen 潘雅欣 |
2024.410 | Effects of High-Intensity Interval Training on Cardiometabolic, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial |
Prof. POON Eric Tsz Chun Eric Tsz-chun Poon |
2024.355 | High-Intensity Interval Exercise and Low-Carbohydrate Diet for Glycaemic Control and Cardiovascular Fitness in Physically Inactive Adults with Prediabetes: A Comparative Randomised Trial |
Prof. POON Eric Tsz Chun 潘梓竣 |
2015.104 | Prospective cohort study of the difference in physical fitness of first team players and the bench players throughout a game season in soccer | Mr Poon Hiu Kong Alfred |
2007.456 | An Uncontrolled Observational Study to Monitor Vascular Access on Haemodilaysis Patients in One Single Centre | RN Poon Ka Lai |
2024.206 | The effectiveness of relaxing music during antenatal ultrasound among high-risk pregnant women to reduce antenatal anxiety. |
Prof. POON Liona Chiu Yee Chiu Yee Liona POON |
2019.484 | Validation of Preeclampsia Detection kit (Point-of-Care test) |
Prof. POON Liona Chiu Yee 潘昭頤 |
2020.473 | Genome-wide cell-free DNA test for fetal chromosomal abnormalities and genomic aberrations |
Prof. POON Liona Chiu Yee 潘昭頤 |
2020.468 | Pregnancy and Neonatal Outcomes in COVID-19: A global registry of women with suspected COVID-19 or confirmed SARS-CoV-2 infection in pregnancy and their neonates; understanding natural history to guide treatment and prevention |
Prof. POON Liona Chiu Yee 潘昭頤 |
2018.410 | Novel Technique for the Detection of Fetal Cells in Maternal Circulation |
Prof. POON Liona Chiu Yee 潘昭頤 |
2018.302 | Evaluation of aspirin non-responsiveness in preeclampsia prevention: a pharmacometabolomic approach |
Prof. POON Liona Chiu Yee 潘昭頤 |
2020.214 | COVID-19 seroconversion during pregnancy |
Prof. POON Liona Chiu Yee 潘昭頤 |
2020.245 | MIND-COVID: Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic – a web-based cross-sectional survey |
Prof. POON Liona Chiu Yee 潘昭頤 |
2018.391 | Implementation of first-trimester screening and prevention of preeclampsia: a stepped wedge cluster-randomized trial in Asia |
Prof. POON Liona Chiu Yee 潘昭頤 |
2018.622 | Genetics association and neurodevelopment in fetal congenital abnormalities |
Prof. POON Liona Chiu Yee 潘昭頤 |
2020.210 | Effect of coronavirus disease 2019 (COVID-19) on maternal and perinatal outcomes and risk of vertical transmission |
Prof. POON Liona Chiu Yee 潘昭頤 |
2020.690 | Prenatal neurosonography in monochorionic twins |
Prof. POON Liona Chiu Yee 潘昭頤 |
2018.019 | Placenta immune cells characterization in pregnancy complications | Prof. POON Liona Chiu Yee |
2017.173 | Gestational normal values of Sylvian angle at 14-36 weeks’ gestation |
Prof. POON Liona Chiu Yee 潘昭頤 |
2016.338 | Ultrasound-based partogram for assessment of progress in labour |
Prof. POON Liona Chiu Yee 潘昭頤 |
2017.472 | Study on “Biomarkers in the prediction of placental complications in pregnancy from assisted reproductive technology” |
Prof. POON Liona Chiu Yee 潘昭頤 |
2017.473 | Study on "Evaluation of Maternal and Fetal Dopplers" |
Prof. POON Liona Chiu Yee 潘昭頤 |
2017.496 | Cervicovaginal Fluid Biomarker for the Identification of Spontaneous Preterm Birth |
Prof. POON Liona Chiu Yee 潘昭頤 |
2016.292 | Maternal cardiac function in high-risk pregnancies with impaired placentation |
Prof. POON Liona Chiu Yee 潘昭頤 |
2016.594 | Vaginal Progesterone for the Prevention of Preterm birth in Twins: A pilot randomised, factorial designed trial – ‘POPPET’ |
Prof. POON Liona Chiu Yee 潘昭頤 |
2017.578 | The Use of Semi-automated Blood Pressure Device for Early Detection of Preeclampsia and Home Monitoring |
Prof. POON Liona Chiu Yee 潘昭儀 |
2021.247 | Integration of ultrasound into partogram for assessment of progress in labour |
Prof. POON Liona Chiu Yee 潘昭頤 |
2022.034 | First-trimester preeclampsia screening: psychological impact on pregnant women throughout pregnancy |
Prof. POON Liona Chiu Yee 潘昭頤 |
2023.559 | Validation of the Fetal Medicine Foundation first-trimester Bayes theorem-based model for the prediction of preeclampsia: an individual-patient-data meta-analysis (FMF-IPDMA) | Prof. POON Liona Chiu Yee |
2021.249 | Labor induction versus expectant management in high-risk women for preeclampsia (FORECAST-IOL) | Prof. POON Liona Chiu Yee |
2023.231 | The Application of Urine Specimen for Women Wellness | Prof. POON Liona Chiu Yee |
2021.406 | Aspirin versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial 早发型子痫前期高风险孕妇使用阿司匹林与二甲双胍的比较: 一项三臂随机对照试验 |
Prof. POON Liona Chiu Yee 潘昭頤 |
2022.467 | Evaluation of first trimester screening performance and cost effectiveness | Prof. POON Liona Chiu Yee |
2022.340 | First-trimester screening and prevention of preeclampsia: prenatal and postpartum follow-up | Prof. POON Liona Chiu Yee |
2022.445 | A point-of-care test for the measurement of placental growth factor for preeclampsia risk stratification | Prof. POON Liona Chiu Yee |
Page 182 of 254.